About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
Malignancy Associated Hemophagocytic Lymphohistiocytosis: Diagnosis & Evaluation, Role of sCD25, Specific Therapeutic Approaches, New Diagnostic Markers
By
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
FEATURING
Sevgi Kalayoglu Besisik
By
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
FEATURING
Sevgi Kalayoglu Besisik
38 views
January 18, 2021
0 Comments
Login to view comments.
Click here to Login
Featured Video
13:04
Winship Cancer Institute - Emory University
Treatment-Related Quality of Life in MF
Feat.
A. Hunter
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Related Content
AUTOPLAY
ON
22:37
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of Acute Leukemia and MDS - Highlig…
Feat.
T. Badar
21:05
Louisville Hematology Highlights
Why Are Our Hematopoietic Stem Cells in the Bone Marrow?
Feat.
R. Gale
06:00
2024 Clinical Case Studies
Clinical Case Review: A Not-So-Sweet Case of Vulvar Ulceration
Feat.
A. Geisler
08:18
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…
Feat.
A. Zhou
12:36
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Myeloid for Measure - New Therapeutics in…
Feat.
A. Patel
16:55
Moffitt Cancer Center
Making Sense of the New Classification Systems for MDS in 2024
Feat.
R. Komrokji
44:26
University of Colorado Division of Hematology
Novel Therapies in AML and MDS
Feat.
D. Pollyea
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
13:07
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Venetoclax With Azacitidine for Pts With Tr…
Feat.
J. Garcia
09:27
ASH 2022 Conference Coverage
MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…
Feat.
M. McMullin
17:21
Daniel Addison
Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…
32:04
Moffitt Cancer Center
Experts Discuss the Latest Data in Myeloid Diseases
Feat.
A. Kuykendall,
R. Komrokji,
O. Chan,
D. Sallman
06:09
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Outcomes of Pts With Richter's Transfo…
Feat.
A. Kittai
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course
Overview of Hematopoietic Cell Transplantation
Feat.
R. Salit
16:25
Northwestern Medicine Oncology and Hematology
Diagnosis and Goals of Therapy in PV
Feat.
B. Stein
16:50
MDS Foundation
Pre-MDS States: How to Manage CHIP, CCUS and ICUS in the Clinic
Feat.
M. Savona
29:20
MyCancerHaven
Experts Discuss Recent Advances in MDS
Feat.
R. Vij,
M. Sekeres
14:34
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "IMerge - Results From a Ph3 Study of Imet…
Feat.
A. Zeidan
30:34
UChicago Medicine
2023 Updates in AML and MDS
Feat.
O. Odenike
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
